LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident
April 25 2024 - 4:03PM
Business Wire
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology
company, today announced that its wholly-owned U.S. subsidiary,
LivaNova USA, Inc., is providing notice to U.S. patients regarding
a cybersecurity incident that was initially disclosed by the
Company on November 20, 2023.
The incident resulted in a disruption to portions of the
Company’s information technology systems. Promptly after detecting
the issue on November 19, 2023, LivaNova began an investigation
with assistance from external cybersecurity experts and coordinated
with law enforcement. The Company took action to remediate the
issue, such as taking certain systems offline, and resumed
manufacturing as previously disclosed. In the course of its
investigation, the Company determined that its systems were first
accessed by an unauthorized party around October 26, 2023.
On April 10, 2024, LivaNova learned that the unauthorized party
obtained certain identifiable personal information of U.S.
patients. While the Company is continuing to analyze the nature and
scope of the affected information, the Company is aware that the
information, which varied by impacted individual, included data
such as name, contact information (e.g., phone number, email and postal address),
Social Security number, date of birth, medical information
(e.g., treatment, condition,
diagnosis, prescription, physician, medical record number and
device serial number), and health insurance information.
On April 25, 2024, LivaNova posted notice of this incident on
its website. The Company is sending notice to affected U.S.
patients for whom it has contact information. The Company’s notice
of this incident includes information on how affected U.S. patients
can enroll in complimentary identity protection and credit
monitoring services. LivaNova encourages affected patients in the
U.S. to remain vigilant for incidents of fraud and identity theft
by reviewing their account statements and monitoring their free
credit reports, and to remain alert for unsolicited communications
involving personal information.
Affected U.S. patients who have questions or would like
additional information about this issue can contact (833) 931-5100
toll-free, Monday through Friday, 8 a.m. to 8 p.m. CT (excluding
major U.S. holidays). Please reference engagement number B121304
when calling. Additional information is available at
www.livanova.com.
About LivaNova
LivaNova PLC is a global medical technology company built on
nearly five decades of experience and a relentless commitment to
provide hope for patients and their families through medical
technologies, delivering life-changing improvements for both the
Head and Heart. Headquartered in London, LivaNova employs
approximately 2,900 employees and has a presence in more than 100
countries for the benefit of patients, healthcare professionals and
healthcare systems worldwide. For more information, please visit
www.livanova.com.
Safe Harbor Statement
This news release contains “forward-looking statements”
concerning the Company’s goals, beliefs, expectations, strategies,
objectives, plans, underlying assumptions and other statements that
are not necessarily based on historical facts. These statements
include, but are not limited to, statements regarding the Company’s
previously disclosed cybersecurity incident. Actual events may
differ materially from those indicated in our forward-looking
statements as a result of various factors, including those factors
set forth in Item 1A of the Company’s most recent Annual Report on
Form 10-K, as supplemented by any risk factors contained in
Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.
LivaNova undertakes no obligation to update the information
contained in this press release to reflect subsequently occurring
events or circumstances.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240425016136/en/
LivaNova Investor Relations and Media Contacts +1
281-895-2382 Briana Gotlin Director, Investor Relations
InvestorRelations@livanova.com Deanna Wilke VP, Corporate
Communications Corporate.Communications@livanova.com
LivaNova (NASDAQ:LIVN)
Historical Stock Chart
From Apr 2024 to May 2024
LivaNova (NASDAQ:LIVN)
Historical Stock Chart
From May 2023 to May 2024